Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of Pharmacokinetic Infliximab Data in Pediatric CD Patients (ProRAPID)

NCT05552287 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05552287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05552287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of Pharmacokinetic Infliximab Data in Pediatric CD Patients (ProRAPID)
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
August 2, 2023
Completion date
August 31, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biologic; inadequate, child, only, crohn disease